Assembly Biosciences, Inc. (ASMB)
28.06
-1.15
(-3.94%)
USD |
NASDAQ |
Mar 12, 11:31
Assembly Biosciences Total Liabilities (Quarterly) : 57.30M for Sept. 30, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Gilead Sciences, Inc. | 36.40B |
| CorMedix, Inc. | 472.32M |
| Supernus Pharmaceuticals, Inc. | 552.44M |
| ACADIA Pharmaceuticals, Inc. | 336.80M |
| Alnylam Pharmaceuticals, Inc. | 4.236B |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 240.00M |
| Shareholders Equity (Quarterly) | 182.70M |
| Debt to Equity Ratio | 0.0151 |
| Current Ratio | 4.436 |
| Net Debt Paydown Yield | -0.05% |